CARERX CORP (CRRX.CA) Stock Fundamental Analysis
Canada - TSX:CRRX - CA14173C1059 - Common Stock
3.56 CAD
+0.06 (+1.71%)
Taking everything into account, CRRX scores 3 out of 10 in our fundamental rating. CRRX was compared to 16 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of CRRX is average, but there are quite some concerns on its profitability. CRRX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRRX has reported negative net income.
CRRX had a positive operating cash flow in the past year.
In the past 5 years CRRX always reported negative net income.
CRRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CRRX has a Return On Assets of -0.83%. This is in the lower half of the industry: CRRX underperforms 75.00% of its industry peers.
With a Return On Equity value of -2.09%, CRRX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CRRX has a worse Return On Invested Capital (3.79%) than 68.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRRX is significantly below the industry average of 8.70%.
The last Return On Invested Capital (3.79%) for CRRX is above the 3 year average (3.05%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -2.09% | ||
| ROIC | 3.79% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of CRRX (2.33%) is worse than 75.00% of its industry peers.
In the last couple of years the Operating Margin of CRRX has grown nicely.
With a Gross Margin value of 29.54%, CRRX is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 29.54% |
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRRX is destroying value.
Compared to 1 year ago, CRRX has more shares outstanding
CRRX has more shares outstanding than it did 5 years ago.
CRRX has a better debt/assets ratio than last year.
2.2 Solvency
CRRX has an Altman-Z score of 1.02. This is a bad value and indicates that CRRX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRRX (1.02) is worse than 87.50% of its industry peers.
The Debt to FCF ratio of CRRX is 3.62, which is a good value as it means it would take CRRX, 3.62 years of fcf income to pay off all of its debts.
CRRX has a Debt to FCF ratio of 3.62. This is amongst the best in the industry. CRRX outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that CRRX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.85, CRRX is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 3.62 | ||
| Altman-Z | 1.02 |
ROIC/WACC0.53
WACC7.13%
2.3 Liquidity
CRRX has a Current Ratio of 1.08. This is a normal value and indicates that CRRX is financially healthy and should not expect problems in meeting its short term obligations.
CRRX has a worse Current ratio (1.08) than 81.25% of its industry peers.
CRRX has a Quick Ratio of 1.08. This is a bad value and indicates that CRRX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, CRRX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
CRRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.73%, which is quite impressive.
The Revenue has decreased by -0.16% in the past year.
CRRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.10% yearly.
EPS 1Y (TTM)72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.63%
3.2 Future
CRRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.49% yearly.
The Revenue is expected to grow by 5.78% on average over the next years.
EPS Next Y307.64%
EPS Next 2Y135.24%
EPS Next 3Y76.49%
EPS Next 5YN/A
Revenue Next Year1.95%
Revenue Next 2Y4.27%
Revenue Next 3Y5.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CRRX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 14.39, the valuation of CRRX can be described as correct.
CRRX's Price/Forward Earnings is on the same level as the industry average.
CRRX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.39 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRRX is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
CRRX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.91 | ||
| EV/EBITDA | 10.86 |
4.3 Compensation for Growth
CRRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRRX's earnings are expected to grow with 76.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y135.24%
EPS Next 3Y76.49%
5. Dividend
5.1 Amount
CRRX has a Yearly Dividend Yield of 2.29%.
Compared to an average industry Dividend Yield of 1.62, CRRX pays a better dividend. On top of this CRRX pays more dividend than 93.75% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CRRX has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
5.2 History
CRRX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y135.24%
EPS Next 3Y76.49%
TSX:CRRX (9/19/2025, 7:00:00 PM)
3.56
+0.06 (+1.71%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners53.54%
Inst Owner ChangeN/A
Ins Owners10.26%
Ins Owner ChangeN/A
Market Cap224.03M
Analysts80
Price Target4.04 (13.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.98%
Min EPS beat(2)-100%
Max EPS beat(2)-1.96%
EPS beat(4)0
Avg EPS beat(4)-164.25%
Min EPS beat(4)-296.08%
Max EPS beat(4)-1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.51%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)1
Avg Revenue beat(12)-2.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.89%
PT rev (1m)0%
PT rev (3m)4.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)43.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.39 | ||
| P/S | 0.61 | ||
| P/FCF | 9.91 | ||
| P/OCF | 7.05 | ||
| P/B | 2.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.86 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.25
Fwd EY6.95%
FCF(TTM)0.36
FCFY10.09%
OCF(TTM)0.51
OCFY14.19%
SpS5.82
BVpS1.38
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.83% | ||
| ROE | -2.09% | ||
| ROCE | 5.27% | ||
| ROIC | 3.79% | ||
| ROICexc | 4.01% | ||
| ROICexgc | 11.71% | ||
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 29.54% | ||
| FCFM | 6.18% |
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexcg growth 3Y15.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.67%
ROICexc growth 5YN/A
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 3.62 | ||
| Debt/EBITDA | 2.7 | ||
| Cap/Depr | 48.72% | ||
| Cap/Sales | 2.51% | ||
| Interest Coverage | 2.01 | ||
| Cash Conversion | 116.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 1.02 |
F-Score7
WACC7.13%
ROIC/WACC0.53
Cap/Depr(3y)51.22%
Cap/Depr(5y)43.4%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y307.64%
EPS Next 2Y135.24%
EPS Next 3Y76.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.63%
Revenue Next Year1.95%
Revenue Next 2Y4.27%
Revenue Next 3Y5.78%
Revenue Next 5YN/A
EBIT growth 1Y-1.59%
EBIT growth 3Y15.72%
EBIT growth 5YN/A
EBIT Next Year370.62%
EBIT Next 3Y66.29%
EBIT Next 5YN/A
FCF growth 1Y-23.56%
FCF growth 3Y480.16%
FCF growth 5Y59.88%
OCF growth 1Y-16.1%
OCF growth 3Y73.54%
OCF growth 5Y42.97%